DAIC

JUNE 12, 2024

and an investigator in the VIVID study , which contributed to the device’s FDA approval – successfully used the Duo Venous Stent System for the first time outside of a clinical trial. Duo Hybrid has a distinct integrated design that combines multiple zones of differing mechanical properties into a single stent [3].

Stent 105

Stent Stents Anatomy Ultrasound 105

Stroke Journal

FEBRUARY 1, 2024

In-silico evaluation (computer simulated analysis in a virtual stroke model) has the potential to test and optimize large number of stent-retriever design variations in a relatively time and cost-effective manner. Gravity Medical Technology’s SuperNova Stent-retriever was the device under investigation.

Stent 40

Stent Stents Blood Clot Anatomy 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

In‐silico evaluation (computer simulated analysis in a virtual stroke model) has the potential to test and optimize large number of stent‐retriever design variations in a relatively time and cost‐effective manner. Further, new design concepts can be tested across multiple anatomical scenarios.

Stent 40

Stent Stents Blood Clot Anatomy 40

AMS Cardiology

NOVEMBER 4, 2023

These modifications contribute to improved blood flow, weight management and overall cardiovascular health. Antiplatelet medicines help to reduce the risk of blood clots while statins help to lower blood cholesterol levels and stabilize plaque in the arteries.

Peripheral Arterial Disease 52

Peripheral Arterial Disease Blood Pressure Diet Exercise 52

DAIC

MARCH 8, 2024

As an alternative therapeutic option, LVAD heart pumps have been implanted to help patients with end-stage heart failure sustain blood circulation in the body. However, there are shortcomings associated with LVAD implantation: complications include infection, blood clotting (thrombosis), stroke and bleeding.

Blood Clot 98

Blood Clot Heart Failure Quality of Life Innovation 98

Cardiometabolic Health Congress

JULY 17, 2024

February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes. The label includes a “black box” warning for CV risk due to blood clots.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Defibrillator 59

DAIC

APRIL 6, 2024

In addition, patients treated with CSL112 were 32% less likely to have a heart attack caused by a blood clot in a stent (a tiny mesh tube inserted into an artery to prevent it from becoming blocked) at 90 days and 29% less likely at 180 days.

Heart Attack 98

Heart Attack Heart attacks Cholesterol Blood Clot 98